ATE552833T1 - Methoxypolyethylenglykol-thioester-chelat und dessen verwendung - Google Patents

Methoxypolyethylenglykol-thioester-chelat und dessen verwendung

Info

Publication number
ATE552833T1
ATE552833T1 AT07750513T AT07750513T ATE552833T1 AT E552833 T1 ATE552833 T1 AT E552833T1 AT 07750513 T AT07750513 T AT 07750513T AT 07750513 T AT07750513 T AT 07750513T AT E552833 T1 ATE552833 T1 AT E552833T1
Authority
AT
Austria
Prior art keywords
methoxypolyethylene glycol
chelate
glycol thioester
mpdte
patient
Prior art date
Application number
AT07750513T
Other languages
English (en)
Inventor
Karl Schellenberg
Frank Lattanzio
James Shaeffer
Original Assignee
Eastern Virginia Med School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Med School filed Critical Eastern Virginia Med School
Application granted granted Critical
Publication of ATE552833T1 publication Critical patent/ATE552833T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/28—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Steroid Compounds (AREA)
AT07750513T 2006-02-14 2007-02-14 Methoxypolyethylenglykol-thioester-chelat und dessen verwendung ATE552833T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77287406P 2006-02-14 2006-02-14
PCT/US2007/003682 WO2007095178A2 (en) 2006-02-14 2007-02-14 Methoxypolyethylene glycol thioester chelate and uses thereof

Publications (1)

Publication Number Publication Date
ATE552833T1 true ATE552833T1 (de) 2012-04-15

Family

ID=38372058

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07750513T ATE552833T1 (de) 2006-02-14 2007-02-14 Methoxypolyethylenglykol-thioester-chelat und dessen verwendung

Country Status (8)

Country Link
US (3) US7388028B2 (de)
EP (2) EP2428234A1 (de)
JP (2) JP5138612B2 (de)
CN (1) CN101394844A (de)
AT (1) ATE552833T1 (de)
AU (1) AU2007215211B2 (de)
CA (1) CA2642453A1 (de)
WO (1) WO2007095178A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007215211B2 (en) 2006-02-14 2010-08-26 Eastern Virginia Medical School Methoxypolyethylene glycol thioester chelate and uses thereof
JP2010100615A (ja) * 2008-09-25 2010-05-06 Santen Pharmaceut Co Ltd ポリアルキレングリコールを有効成分として含有する網膜疾患の予防又は治療剤
TWI568453B (zh) * 2011-11-22 2017-02-01 原創生醫股份有限公司 具有螯合型複合微胞之藥物載體及其應用
JP6086576B2 (ja) * 2012-04-24 2017-03-01 公立大学法人首都大学東京 抗酸化剤
WO2018236221A2 (en) * 2017-06-03 2018-12-27 Can Holding B.V. DISSOLUTION OF NEURODEGENERATIVE PEPTIDE DEPOSITION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
JP2722250B2 (ja) 1989-05-30 1998-03-04 興和株式会社 新規なジアミン化合物及びこれを含有する脳機能障害改善剤
JPH0680964A (ja) * 1991-12-27 1994-03-22 Sogo Yatsukou Kk 活性酸素消去剤
EP0841951A2 (de) * 1995-06-26 1998-05-20 Concat Ltd. Verbindungen mit chelatbildungs- und spezifizitätseigenschaften für elemente der ersten übergangsgruppe sowie deren verwendung in der medizinischen therapie und diagnostik
US6020373A (en) * 1995-10-20 2000-02-01 Eastern Virginia Medical School Chelate derivatives as protectors against tissue injury
AU7454796A (en) 1995-10-20 1997-05-07 Eastern Virginia Medical School Chelate derivatives as protectors against tissue injury
AU2003297511B2 (en) * 2002-12-20 2010-01-21 Chakshu Research, Inc. Ophthalmic formulation for the prevention and treatment of ocular conditions
AU2007215211B2 (en) * 2006-02-14 2010-08-26 Eastern Virginia Medical School Methoxypolyethylene glycol thioester chelate and uses thereof

Also Published As

Publication number Publication date
JP2009527474A (ja) 2009-07-30
JP2012031173A (ja) 2012-02-16
WO2007095178A3 (en) 2008-04-17
US20080039524A1 (en) 2008-02-14
CA2642453A1 (en) 2007-08-23
US8008347B2 (en) 2011-08-30
US7388028B2 (en) 2008-06-17
US20090306205A1 (en) 2009-12-10
US8796336B2 (en) 2014-08-05
JP5138612B2 (ja) 2013-02-06
US20120016030A1 (en) 2012-01-19
EP1986631A4 (de) 2010-10-27
AU2007215211B2 (en) 2010-08-26
AU2007215211A1 (en) 2007-08-23
EP1986631B1 (de) 2012-04-11
WO2007095178A2 (en) 2007-08-23
EP1986631A2 (de) 2008-11-05
EP2428234A1 (de) 2012-03-14
CN101394844A (zh) 2009-03-25

Similar Documents

Publication Publication Date Title
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
CY1110969T1 (el) 5-υποκατεστημενα-2-φαινυλαμινο-βενζαμιδια ως αναστολεiς μεκ
MY159463A (en) Method and composition for treating ocular hypertension and glaucoma
WO2004047747A3 (en) Compositions and methods for cell dedifferentiation and tissue regeneration
ATE552833T1 (de) Methoxypolyethylenglykol-thioester-chelat und dessen verwendung
WO2010093849A3 (en) Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
DE602006002366D1 (de) Androstan-17-alpha-carbonat zur verwendung bei der behandlung entzündlicher und allergischer zustände
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
MX2009006598A (es) Derivados de sulfamida como transferasa de carnitina palmitoil del higado (l-cptl).
WO2006093547A3 (en) Novel lipoxygenase inhibitors
NO20060114L (no) Naftylenderivater som cytokrom P450-inhibitorer
WO2006044425A3 (en) Ophthalmic compositions for treating ocular hypertension
MXPA06012566A (es) Tratamiento de enfermedades infecciosas.
WO2008054698A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
TW200738651A (en) Cyclohexyl sulfonamide derivatives
TR201908487T4 (tr) Oftalmolojik bileşimler ve kullanımları.
WO2004069181A3 (en) Composition for the treatment of intraocular pressure
DE602005027677D1 (de) 1,3,4-oxadiazol-2-one als ppar-delta-modulatoren und deren verwendung
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases
EA201100872A1 (ru) Производные хиназолинамида
CY1110644T1 (el) 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις
PL2114406T3 (pl) Pochodne tioksantenowe jako środki przeciw-infekcyjne do zastosowania w leczeniu chorób zakaźnych
WO2006020003A3 (en) Ophthalmic compositions for treating ocular hypertension
EP2073635A4 (de) Makrozyklische spiropiperidin-beta-sekretase-hemmer zur behandlung von morbus alzheimer
MX2012003693A (es) Composiciones de olopatadine y usos de las mismas.